Iqvia (IQV) announced a strategic collaboration with Nvidia (NVDA) to help realize the potential of AI in healthcare and life sciences. Discover outperforming stocks and invest smarter with Top ...

Companies including Illumina (ILMN) and IQVIA (IQV) are currently using Nvidia technology. The tech giant said that its technology, such as AI processes, can accelerate clinical trials by reducing ...

How Virtual Clinical Trials Are Speeding The Path To Another Vaccine For decades, IQVIA has been helping pharmaceutical ... With technology like the Salesforce Customer 360, you can strengthen ...

RESEARCH TRIANGLE PARK, N.C., January 13, 2025--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights, and healthcare intelligence ...

Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s full-year ...

Barclays lowered the firm’s price target on Iqvia (IQV) to $235 from $255 and keeps an Overweight rating on the shares. The firm says the life science tools group will likely continue to work ...